Embecta (EMBC) Capital Expenditures (2020 - 2026)
Embecta (EMBC) posted Capital Expenditures of $500000.0 for Q1 2026, down 16.67% sequentially from $600000.0 in Q4 2025, and up 400.0% YoY from $100000.0 in Q1 2025.
Embecta (EMBC) Capital Expenditures (2020 - 2026) Analysis & Trends
Embecta has reported Capital Expenditures for 7 years, with the latest figure at $500000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 400.0% year-over-year to $500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (down 22.12% YoY) and the FY2025 annual result came in at $9.3 million, down 41.14% from the prior year.
- Capital Expenditures fell to $500000.0 in Q1 2026 per EMBC's latest filing, from $600000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $9.7 million in Q2 2024 and troughed at $100000.0 in Q1 2025.
- A 5-year average of $4.5 million and a median of $5.0 million in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2025 and 2026: Capital Expenditures plunged 97.06% in 2025, then surged 400.0% in 2026.
- Over 5 years, Capital Expenditures stood at $4.7 million in 2022, then sank by 42.55% to $2.7 million in 2023, then sank by 44.44% to $1.5 million in 2024, then slumped by 60.0% to $600000.0 in 2025, then fell by 16.67% to $500000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $500000.0, $600000.0, and $7.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.42 Bn | 129.20 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.59 Bn | 51.72 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.74 Bn | 34.38 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.69 Bn | 32.22 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.14 Bn | 26.46 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.05 Bn | 24.62 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.41 Bn | 15.01 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Embecta | 305.55 Mn | 87.35 Mn | 153.30 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 500,000.00 |
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 7.30 Mn |
| Sep 30, 2025 | 7.30 Mn |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Jun 30, 2024 | 9.70 Mn |
| Jun 30, 2024 | 9.70 Mn |
| Mar 31, 2024 | 3.40 Mn |
| Mar 31, 2024 | 3.40 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Dec 31, 2023 | 2.70 Mn |